EP1781804A1 - Verfahren und vorrichtung zum messen von enzymaktivität in einer körperflüssigkeit - Google Patents
Verfahren und vorrichtung zum messen von enzymaktivität in einer körperflüssigkeitInfo
- Publication number
- EP1781804A1 EP1781804A1 EP05796245A EP05796245A EP1781804A1 EP 1781804 A1 EP1781804 A1 EP 1781804A1 EP 05796245 A EP05796245 A EP 05796245A EP 05796245 A EP05796245 A EP 05796245A EP 1781804 A1 EP1781804 A1 EP 1781804A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- denotes
- substrate
- enzymatic activity
- electroactive
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 230000002255 enzymatic effect Effects 0.000 title claims abstract description 39
- 210000001124 body fluid Anatomy 0.000 title abstract 3
- 239000010839 body fluid Substances 0.000 title abstract 3
- 239000000758 substrate Substances 0.000 claims abstract description 46
- 102000004190 Enzymes Human genes 0.000 claims abstract description 21
- 108090000790 Enzymes Proteins 0.000 claims abstract description 21
- 238000005259 measurement Methods 0.000 claims abstract description 21
- 238000006911 enzymatic reaction Methods 0.000 claims abstract description 9
- 230000023555 blood coagulation Effects 0.000 claims abstract description 4
- 229940088598 enzyme Drugs 0.000 claims description 20
- 239000013060 biological fluid Substances 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
- 229910052737 gold Inorganic materials 0.000 claims description 14
- 239000010931 gold Substances 0.000 claims description 14
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 125000006850 spacer group Chemical group 0.000 claims description 9
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims description 7
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims description 7
- 239000003114 blood coagulation factor Substances 0.000 claims description 7
- 108090000190 Thrombin Proteins 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 229960004072 thrombin Drugs 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 5
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 5
- 238000002848 electrochemical method Methods 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000003636 chemical group Chemical group 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000000295 complement effect Effects 0.000 claims description 2
- 230000003100 immobilizing effect Effects 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910000510 noble metal Inorganic materials 0.000 claims description 2
- 230000000737 periodic effect Effects 0.000 claims description 2
- 150000008430 aromatic amides Chemical group 0.000 claims 2
- 239000013545 self-assembled monolayer Substances 0.000 description 20
- 239000002094 self assembled monolayer Substances 0.000 description 18
- 230000015271 coagulation Effects 0.000 description 14
- 238000005345 coagulation Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000010410 layer Substances 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 9
- 108090000631 Trypsin Proteins 0.000 description 8
- 102000004142 Trypsin Human genes 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- 108091005804 Peptidases Proteins 0.000 description 7
- ATGUVEKSASEFFO-UHFFFAOYSA-N p-aminodiphenylamine Chemical compound C1=CC(N)=CC=C1NC1=CC=CC=C1 ATGUVEKSASEFFO-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical compound CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000004082 amperometric method Methods 0.000 description 2
- 150000004982 aromatic amines Chemical group 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000003130 blood coagulation factor inhibitor Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000033116 oxidation-reduction process Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- -1 polyethylene chain Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 238000001075 voltammogram Methods 0.000 description 2
- AKGWUHIOEVNNPC-LURJTMIESA-N Arg-OEt Chemical compound CCOC(=O)[C@@H](N)CCCNC(N)=N AKGWUHIOEVNNPC-LURJTMIESA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010053317 Hydrophobia Diseases 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- KZNMRPQBBZBTSW-UHFFFAOYSA-N [Au]=O Chemical class [Au]=O KZNMRPQBBZBTSW-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 229910001922 gold oxide Inorganic materials 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 239000002052 molecular layer Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 238000002494 quartz crystal microgravimetry Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Definitions
- the invention relates to the field of biological analyzes and more particularly relates to a method and a device for measuring an enzymatic activity in a biological fluid, especially in whole blood.
- plasma preparation requires a number of pre-analytical steps and is also a source of potential errors.
- This patent describes more particularly a method for assaying proteases and anti-proteases, and in particular proteases and anti-proteases of the coagulation and complement systems.
- This process consists in reacting the enzyme to be assayed on an electrochemically neutral substrate but which, after hydrolysis by the enzyme, produces a hydrolysis product capable of being either oxidized or electrochemically reduced in the electro-electrochemical field. - Activity of the system, this product is then determined by amperometry at a pH between 6 and 10.
- the dosage of the enzyme is carried out here by a particular electrical measurement, defined in the patent.
- a particular example of the substrate used is benzoyl-D, L-arginyl-p-aminodiphenylamide chloride.
- the enzymatic reaction then makes it possible to release the corresponding amine, namely lap-aminodiphenylamine, also called pAD ⁇ , by abbreviation.
- this known method of assaying and measuring coagulation proteases and protease proteases is carried out only in a homogeneous medium, ie in solution.
- Patent EP 1 031 830 in the name of ASULAB, is largely based on the electrochemical sensor principle of US Pat. No. 4,304,853 mentioned previously.
- ASULAB proposes to measure the prothrombin time by measuring the electrical activity generated by an enzymatic reaction with a charged generator-generated electrolytic substrate that can be cut from its chain by thrombin.
- the surface on which the substrate is fixed is a platinum or silver layer.
- reaction is carried out in a homogeneous medium, that is to say in solution.
- the publication WO 01/36666 of the company I-STAT relates to an apparatus for the measurement of coagulation using an electrochemical sensor.
- the equipment uses a reagent to trigger a coagulation reaction. Sensors then directly measure the enzymatic activity responsible for coagulation.
- reaction described in the patent is a reaction in a homogeneous medium, that is to say in solution.
- the invention aims in particular to improve the situation by proposing a new method and a new device for measuring an enzymatic activity in a biological fluid, which avoids the disadvantages of the prior art. It is in particular an object of the invention to provide such a method and such a device which are suitable for the measurement of different enzymatic activities in biological fluids of various natures, and in particular in turbid and / or colored biological fluids, as is the case with whole blood.
- the invention more particularly relates to a method for measuring an enzymatic activity in a biological fluid, which comprises the following operations:
- the invention thus makes it possible to reveal an electroactive product serving as a marker and which can be released from the support or remain attached to the support, the quantity of which provides a direct measurement of the enzymatic activity by amperometry.
- - substrate molecule recognized and transformed by the enzyme
- marker the product of an enzymatic reaction which is an electroactive group detectable by an electrode
- micro or submicrovolumetric typically less than 100 microliters
- the substrate is deposited in the form of at least one monomolecular layer of molecules corresponding to one of the following general formulas I and II:
- S denotes a chemical group capable of forming a bond with the conductive surface
- C n denotes a methylenic aliphatic chain consisting of n carbon atoms
- E denotes a non-electroactive hydrophilic spacer of the polyethylene glycol type, optionally present to complete the C n chain,
- P denotes a polypeptide sequence specific for the enzymatic activity to be measured
- X denotes an electroactive residue capable of being oxidized or reduced in a range of potential accessible in the medium.
- n is an integer from 9 to 18.
- the conductive surface of the support is modified by deposition of a monomolecular layer or monomolecular strata of molecules corresponding to one or other of the general formulas I and II mentioned above.
- These molecules have the property of self-assembling spontaneously on the conductive surface. They are also called SAM, abbreviation of the English expression “SELF-ASSEMBLED MONOLAYERS” which means “self-assembled monolayers”.
- the hydrophilic spacer E is optional. Its insertion in the sequence of formula I or of formula II is useful for increasing the surface hydrophilicity of the substrate, on the solution side, thus reducing possible phenomena of short-range repulsion, irreversible adsorption or denaturation of the substrate. the enzyme as it approaches the surface.
- S denotes a thiol group
- C n denotes a hydrophobic carbon chain comprising n hydrocarbon chains, in particular methylene, and supporting a hydrophilic spacer
- E denotes a peptide sequence, at least two amino acids of a substrate specific for the enzymatic activity to be measured
- X is an aromatic amine, in particular para-aminodiphenylamide.
- S thus denotes a thiol group, also called sulfhydryl, connected to a carbon chain comprising n methylene chains (n is typically of the order of ten) and supporting a hydrophilic spacer E.
- n is typically of the order of ten
- E hydrophilic spacer
- P denotes a peptide sequence having at least two amino acids, typically between two and five amino acids. This peptide is chosen for its character of specificity with respect to the enzyme to be measured, for example thrombin, in the case of the measurement of an activity related to the coagulation of blood.
- X is advantageously an aromatic amine, in particular para-aminodiphenylamide.
- Enzymatic hydrolysis reveals the corresponding amine, p-amino diphenylamine.
- This amine was chosen for its appreciable hydrophobicity. This property favors the sensitivity of the detection insofar as it increases the partition coefficient: concentration of the free amine in the substrate / concentration of the free amine in solution.
- the amine is oxidized at low potentials, which makes it readily detectable in the presence of also oxidizable interferers, such as ascorbic acid.
- the invention is of particular interest in the case where the biological fluid is a cloudy fluid and / or colored, as is the case of whole blood.
- the enzymatic activity to be measured may be that of a coagulation factor or the complement of whole blood, in particular of a coagulation factor such as thrombin.
- enzymatic activity can be used to assay an endogenous or exogenous blood coagulation inhibitor or co-factor, knowing that the factors and inhibitors may be physiological or exogenous.
- Exogenous inhibitors include, in particular, heparin, a substance administered to patients to inhibit blood clotting.
- a drop of the sample in particular whole blood
- the substrate in particular an active sensor, the place of measurement, allows a rapid and direct detection of enzymatic activities sought.
- the invention makes it possible to avoid all the conventional pre-analytical steps necessary for the preparation of the plasma, which saves time and eliminates sources of errors. potential.
- the invention makes it possible to measure an enzymatic activity from a sample of small volume of the biological fluid.
- the enzyme that is to be quantified reacts with the immobilized substrate.
- This enzymatic reaction generates an electro-active product detected by the measuring electrode integrated in the sensor.
- the amplitude of the measured signal is proportional to the amount of product formed during the reaction, which makes it possible to know the activity of the coagulation factor.
- This measurement system can be used directly by the patient or through a hospital staff.
- One of the advantages of the invention is to allow a very rapid measurement of enzymatic activities, for example coagulation factors or coagulation inhibitors.
- the invention is therefore particularly applicable in emergency rooms as a rapid diagnostic tool, or in the patient, to measure the evolution of a specific enzymatic activity.
- the conductive surface is advantageously a layer of a metal capable of immobilizing the covalent molecules (I) or (II), in particular gold.
- a metal capable of immobilizing the covalent molecules (I) or (II), in particular gold.
- it is a layer of gold deposited on a support based on silicon.
- the detection operation is performed with electrodes which typically include a working electrode, a counter electrode and optionally a reference electrode.
- the working electrode is advantageously constituted by the support itself.
- the counter electrode and the reference electrode may be distinct; however, it is advantageous that the counter-electrode and the reference electrode are combined, the counter electrode then serving as a potential reference.
- the detection operation advantageously comprises the measurement of the amplitude of a signal proportional to the quantity of electro-active product revealed during the enzymatic reaction.
- the invention relates to a device for measuring an enzymatic activity in a biological fluid, which can be used for carrying out the method defined above.
- This device essentially comprises:
- the substrate is advantageously deposited in the form of at least one monomolecular layer of molecules corresponding to one or other of the general formulas I and II as mentioned above. Therefore, the characteristics defined previously for the method also apply to the device.
- the amperometric detection means comprise a specific potentiostat to deliver between the working electrodes and the reference electrode a periodic and adjustable potential difference to the detection domain of the marker.
- FIG. 1 is the structural formula of an example of a substrate according to the invention.
- FIG. 2 represents the structural formula of the peptide sequence of the substrate of FIG. 1;
- FIG. 3 is a perspective view of an electrode according to the invention.
- FIG. 4 is a perspective view of a measuring cell used in the invention.
- FIG. 5 represents the amperometric detection of p-aminodiphenylamine (pADA) in solution by a surface of gold modified by a monolayer of the substrate whose formula is represented in FIG. 1;
- pADA p-aminodiphenylamine
- FIG. 6 represents the gradual variation of a voltammetric current recorded during a kinetics of hydrolysis in the presence of 80 mU / ml of trypsin; and
- FIG. 7 is a graph showing the evolution of the currents of FIG. 6 as a function of time.
- Trypsin is a protease in the same way as the enzymes of hemostasis. Trypsin is a protease in the same way as the enzymes of hemostasis.
- the system used comprises a conductive surface, preferably a noble metal such as gold, modified by deposition of a monomolecular layer or monomolecular strata of molecules corresponding to one or other of the general formulas I and II such than previously mentioned.
- S is a thiol group (also called sulfhydryl)
- C n is a carbon chain comprising eleven methylene linkages
- E is a hydrophilic spacer of the hexa-ethylene glycol type
- P is a tripeptide sequence of a substrate hydrolyzed by the trypsin (the formula is shown in Figure 2)
- X is para-aminodiphenylamide.
- the amine which will be released by erizymatic hydrolysis namely p-aminodiphenylamine, was chosen because of its appreciable hydrophobicity, as mentioned above.
- This amine is oxidized at low potentials, which makes it readily detectable in the presence of interfering also oxidizable, such as ascorbic acid.
- This surface is a rectangular bar 1 (see Figure 3) having a surface layer of gold 2 deposited on a titanium layer 3, itself deposited on a strip 4 based on silicon.
- the gold layer has a thickness of 3000 Angstroms, the titanium layer 300 Angstrom and the silicon bar 500 microns.
- the whole is annealed for twenty minutes at 250 ° C. under vacuum.
- the process is carried out according to the usual techniques of elaboration of information media in microcomputer or microelectronics.
- SAM self-assembled monolayer
- the surface handled with non-paraffinized protective gloves, is carefully degreased with acetone, then with ethanol, then rinsed with ultra pure water, again with ethanol and finally dried under a stream of nitrogen. It is then used as a working electrode in a conventional three-electrode electrochemical assembly (working electrode, counter-electrode and reference electrode) and immersed in a solution of pure water containing 0.5% by volume of sulfuric acid.
- the i / E curve (current / potential) then reveals a series of peaks attributed to the formation of gold oxides in the region 1.2-1.5 V followed, after inversion of the potential, of a peak
- the integration of the reduction peak makes it possible to evaluate the effective surface of the electrode and therefore, in comparison with the geometrical surface, the roughness.
- the electrode is removed from the solution to a final potential of 0.0 V leaving the gold free of oxides detrimental to SAM formation, as described in the literature.
- the deposition of the assembled monolayer will now be described.
- the strip After vigorous rinsing with ultra pure water, the strip is left stirring and at room temperature for at least twelve hours in 10 ml of ethanol containing a homogeneous mixture of electrogenic substrate and mercapto-hexanol coupled to a polyethylene chain.
- C 3 glycol in a proportion of between 0.1 and 10% respectively calculated to obtain a total concentration of 0.1 mM.
- the mercapto-hexanol acts as a diluent of the substrate of FIG. 1 on the surface.
- electrochemical desorption this method consists of subjecting the modified surface to a reduction potential sweep from 0 to -1.4 V in 0.5 M KOH medium at 0.05 V / s. Under these conditions, each set of bonds (Au-S) present on the surface undergoes an electrochemical reduction which results in the desorption of the organic molecule. This reaction consumes electrons. There is therefore a peak of desorption whose potential is characteristic of each thiol. Integration of the peak gives the surface density of the thiol.
- the immobilized electrogenic substrate has an oxidation signal located above 0.4 V corresponding to the oxidation of X coupled to the substrate. Integration of the response gives the surface density of the thiol.
- a SAM deposited on gold supported by a quartz crystal is suitable for weighing by the QCM technique.
- reversible redox markers permeation using reversible redox markers.
- the kinetics of the gradual modification of gold by the SAM is followed by the evolution of the cyclo-voltametric signal of simple redox couples known to give a reversible or quasi-reversible signal, such as the Fe (CN) 6 3 ' ' pair. 4 - (hexacyanoferrate ffl / II) or Ru (CN) 6 3 + / 2 + (hexacyanoruthenate IMI).
- the reversibility of the signals is characterized by a separation of the anodic and cathodic oxidation-reduction peaks of the order of 65-80 mV in Tris medium 0.15 M / KC10.5 M pH 7.4.
- the residual current obtained in the presence of a SAM lowers the residual current of the bare surface due to the capacity of the self-assembled molecular layer.
- the typical capacity of the bare double layer, of the order of 20 ⁇ F / cm 2 on bare gold drops to 2 to 6 ⁇ F / cm 2 after modification.
- the capacity of the SAM of the support having the formula of Figure 1 is insensitive to the potential.
- the electrochemical analysis is carried out by means of a device as shown in FIG. 4.
- the electrochemical analysis of the trypsin activity is carried out in a cylindrical polytetrafluoroethylene tank containing 5 ml of 0.15 M Tris buffer. 0.5M KC1 at pH 7.4 using strip 1 as the working electrode, a platinum wire 11 as a counter electrode and an Ag / AgCl 12 electrode as a reference electrode inserted laterally into the vessel, leaving no contact the solution as the tip to minimize protein adsorptions on the glass. It is also possible to put at stake only two electrodes: the working electrode and a silver wire which then acts as a pseudo ⁇ reference, provided that the two electrodes are sufficiently separated so that the phenomena which take place on the counter electrode do not interfere with each other. not with those taking place on the working electrode.
- the surface of the bar, placed horizontally under the tank, is accessible to the solution by a circular view 13 made through the bottom of the tank. Sealing is provided by mechanical pressure exerted by a mechanical clamping system 14 and by interposition of a solvent-resistant polymer O-ring 15 between the tank and the bar.
- the response of the modified surface in the presence of trypsin is obtained by applying a triangular voltammetric signal train between 0.0 and 0.35 V at a rate of 0.1 V / s and periodically at a frequency which depends on the enzyme concentration (between 10 and 300s).
- the maximum potential must not exceed 0.35 V in order to avoid the risk of oxidizing the unhydrolyzed substrate. This limit also aims to not affect the integrity of the SAM.
- the above method and device can be applied to measure other enzymatic activities in a biological fluid, including enzymatic activities related to coagulation of whole blood.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Sustainable Development (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0408960A FR2874385B1 (fr) | 2004-08-18 | 2004-08-18 | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique |
| PCT/FR2005/002031 WO2006024788A1 (fr) | 2004-08-18 | 2005-08-05 | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1781804A1 true EP1781804A1 (de) | 2007-05-09 |
Family
ID=34950074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP05796245A Withdrawn EP1781804A1 (de) | 2004-08-18 | 2005-08-05 | Verfahren und vorrichtung zum messen von enzymaktivität in einer körperflüssigkeit |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20070269854A1 (de) |
| EP (1) | EP1781804A1 (de) |
| JP (1) | JP2008509693A (de) |
| FR (1) | FR2874385B1 (de) |
| WO (1) | WO2006024788A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI516601B (zh) * | 2007-10-26 | 2016-01-11 | 環球生物醫療感測器私人有限公司 | 電化學檢測之裝置及方法 |
| WO2014018899A1 (en) * | 2012-07-27 | 2014-01-30 | Ohmx Corporation | Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes |
| US12251991B2 (en) | 2020-08-20 | 2025-03-18 | Denso International America, Inc. | Humidity control for olfaction sensors |
| US12269315B2 (en) | 2020-08-20 | 2025-04-08 | Denso International America, Inc. | Systems and methods for measuring and managing odor brought into rental vehicles |
| US12017506B2 (en) | 2020-08-20 | 2024-06-25 | Denso International America, Inc. | Passenger cabin air control systems and methods |
| US11636870B2 (en) | 2020-08-20 | 2023-04-25 | Denso International America, Inc. | Smoking cessation systems and methods |
| US12377711B2 (en) | 2020-08-20 | 2025-08-05 | Denso International America, Inc. | Vehicle feature control systems and methods based on smoking |
| US11760169B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Particulate control systems and methods for olfaction sensors |
| US11881093B2 (en) | 2020-08-20 | 2024-01-23 | Denso International America, Inc. | Systems and methods for identifying smoking in vehicles |
| US11813926B2 (en) | 2020-08-20 | 2023-11-14 | Denso International America, Inc. | Binding agent and olfaction sensor |
| US11760170B2 (en) | 2020-08-20 | 2023-09-19 | Denso International America, Inc. | Olfaction sensor preservation systems and methods |
| US11828210B2 (en) | 2020-08-20 | 2023-11-28 | Denso International America, Inc. | Diagnostic systems and methods of vehicles using olfaction |
| US11932080B2 (en) | 2020-08-20 | 2024-03-19 | Denso International America, Inc. | Diagnostic and recirculation control systems and methods |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4140662A (en) * | 1977-03-25 | 1979-02-20 | Ortho Diagnostics, Inc. | Attachment of proteins to inert particles |
| EP0018002B1 (de) * | 1979-04-24 | 1983-02-09 | Marcel Jozefonvicz | Neues Bestimmungsverfahren für Proteasen und Antiproteasen |
| US4379780A (en) * | 1980-09-29 | 1983-04-12 | American Home Products Corporation | 17 α-Dihydroequilin hapten and assay method |
| US4680338A (en) * | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| US5491097A (en) * | 1989-06-15 | 1996-02-13 | Biocircuits Corporation | Analyte detection with multilayered bioelectronic conductivity sensors |
| EP0889751B1 (de) * | 1996-04-03 | 1999-09-08 | The Perkin-Elmer Corporation | Vorrichtung und verfahren zum nachweis mehrerer analyten |
| DE69941563D1 (de) * | 1999-02-23 | 2009-12-03 | Asulab Sa | Elektrochemisches System zur Bestimmung der Blutgerinnungszeit |
| CA2363827A1 (en) * | 1999-02-23 | 2000-08-31 | Pentapharm Ag | Oligopeptide derivatives for the electrochemical measurement of protease activity |
| EP1234053B1 (de) * | 1999-11-15 | 2007-04-18 | I-Stat Corporation | Vorrichtung und verfahren zum bestimmen der koagulation in flüssigproben |
| CA2400651A1 (en) * | 2000-02-21 | 2001-08-30 | F. Hoffmann-La Roche Ag | Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| JP4435454B2 (ja) * | 2001-09-03 | 2010-03-17 | 富士フイルム株式会社 | バイオセンサー用表面 |
-
2004
- 2004-08-18 FR FR0408960A patent/FR2874385B1/fr not_active Expired - Fee Related
-
2005
- 2005-08-05 US US11/573,797 patent/US20070269854A1/en not_active Abandoned
- 2005-08-05 WO PCT/FR2005/002031 patent/WO2006024788A1/fr not_active Ceased
- 2005-08-05 JP JP2007526506A patent/JP2008509693A/ja active Pending
- 2005-08-05 EP EP05796245A patent/EP1781804A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2006024788A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2874385A1 (fr) | 2006-02-24 |
| FR2874385B1 (fr) | 2006-12-08 |
| WO2006024788A1 (fr) | 2006-03-09 |
| WO2006024788A8 (fr) | 2007-03-15 |
| US20070269854A1 (en) | 2007-11-22 |
| JP2008509693A (ja) | 2008-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bagal-Kestwal et al. | Invertase inhibition based electrochemical sensor for the detection of heavy metal ions in aqueous system: Application of ultra-microelectrode to enhance sucrose biosensor's sensitivity | |
| EP0409896B2 (de) | Enzymelektrode und verfahren zur herstellung | |
| US10307092B2 (en) | Semiconductor based analyte sensors and methods | |
| JP4731554B2 (ja) | 被検物センサならびにその製造方法および使用方法 | |
| Ali et al. | A fast and sensitive potentiometric glucose microsensor based on glucose oxidase coated ZnO nanowires grown on a thin silver wire | |
| JP5595038B2 (ja) | 分析物センサ装置ならびにその製造方法、組成物及びキット | |
| Şenel et al. | Novel reagentless glucose biosensor based on ferrocene cored asymmetric PAMAM dendrimers | |
| US20040063167A1 (en) | Minimising calibration problems of in vivo glucose sensors | |
| WO2006024788A1 (fr) | Procede et dispositif de mesure d'une activite enzymatique dans un fluide biologique | |
| Vidal et al. | Amperometric cholesterol biosensor based on in situ reconstituted cholesterol oxidase on an immobilized monolayer of flavin adenine dinucleotide cofactor | |
| EP0276782A2 (de) | Verfahren zur Herstellung von Enzymelektroden | |
| Cha et al. | S-nitrosothiol detection via amperometric nitric oxide sensor with surface modified hydrogel layer containing immobilized organoselenium catalyst | |
| Rhemrev-Boom et al. | On-line continuous monitoring of glucose or lactate by ultraslow microdialysis combined with a flow-through nanoliter biosensor based on poly (m-phenylenediamine) ultra-thin polymer membrane as enzyme electrode | |
| JP2020507773A (ja) | 架橋された酵素を用いた持続的な分析物モニタリング電極 | |
| Rahman | Fabrication of mediator-free glutamate sensors based on glutamate oxidase using smart micro-devices | |
| FR3035221A1 (fr) | Biocapteurs electrochimiques implantables | |
| JP2008509693A5 (de) | ||
| Baş et al. | Amperometric biosensors based on deposition of gold and platinum nanoparticles on polyvinylferrocene modified electrode for xanthine detection | |
| Rahman et al. | Selective choline biosensors based on choline oxidase co-immobilized into self-assembled monolayers on micro-chips at low potential | |
| FR2952800A1 (fr) | Dispositif electrochimique pour la determination de proprietes antioxydantes de la peau | |
| JPWO2019176339A1 (ja) | バイオセンサプローブ用保護膜材料 | |
| Portaccio et al. | Amperometric glucose determination by means of glucose oxidase immobilized on a cellulose acetate film: dependence on the immobilization procedures | |
| WO2024055110A1 (en) | Sensor, kit, and method for biomarker detection in saliva | |
| CA2005624C (fr) | Biocapteur a enzyme destine a la mesure directe d'au moins un parametre biochimique de la peau, procede de preparation de la membrane enzymatique associee et procede de mesure correspondant | |
| Yin et al. | A novel amperometric hydrogen peroxide biosensor based on immobilization of hemoglobin in linoleic acid monolayer by Langmuir–Blodgett technique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20070213 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NIGRETTO, JEAN-MAXIME Inventor name: PARIS, MARIELLE Inventor name: LAMBLIN, GUILLAUME Inventor name: BENATTAR, NORBERT |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PARIS, MARIELLE Inventor name: NIGRETTO, JEAN-MAXIME Inventor name: LAMBLIN, GUILLAUME Inventor name: BENATTAR, NORBERT |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20081114 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090526 |